Andean Precious Metals Corp. (CVE:APM – Get Free Report) Senior Officer Juan Carlos Sandoval Amare bought 31,300 shares of Andean Precious Metals stock in a transaction dated Friday, January 3rd. The stock was purchased at an average price of C$1.21 per share, with a total value of C$37,860.48.
Andean Precious Metals Trading Up 7.5 %
Shares of APM opened at C$1.29 on Thursday. The stock has a 50 day moving average of C$1.33 and a 200 day moving average of C$1.26. Andean Precious Metals Corp. has a 12 month low of C$0.57 and a 12 month high of C$2.18. The company has a market capitalization of C$192.67 million, a price-to-earnings ratio of 3.39 and a beta of 1.22.
Wall Street Analyst Weigh In
Separately, Desjardins upgraded shares of Andean Precious Metals to a “moderate buy” rating in a research note on Thursday, October 31st.
About Andean Precious Metals
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.
Recommended Stories
- Five stocks we like better than Andean Precious Metals
- How to buy stock: A step-by-step guide for beginners
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- NYSE Stocks Give Investors a Variety of Quality Options
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Andean Precious Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andean Precious Metals and related companies with MarketBeat.com's FREE daily email newsletter.
